Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014, 158(4):539-543 | DOI: 10.5507/bp.2014.041
Preparing compound heterozygous reference material using gene synthesis technology: a model of thrombophilic mutations
- a Institute of Clinical Biochemistry and Diagnostics, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital Hradec Kralove, Czech Republic
- b 4th Department of Internal Medicine - Hematology, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital Hradec Kralove
Aims: The aim of our study is to present a novel approach for preparing a compound heterozygous reference material (hetRM) using gene synthesis technology with inverted insertion of wild-type and mutant fragments into a single cloning vector. Factor II (G20210A) and Factor V (G1691A Leiden) gene mutations were used as an experimental model.
Methods: During the gene synthesis, DNA fragments were aligned in the following order: G1691 FV wild-type forward strain, G20210 FII wild-type forward strain, 1691A FV mutant reverse strain, 20210A FII mutant reverse strain. The complete chain was inserted into a pIDT SMART cloning vector and amplified in an E. coli competent strain. For assessing hetRM characteristics and commutability, we used real-time PCR with subsequent melting curve analysis, real-time PCR with hydrolysis probes, allele-specific amplification, reverse hybridization, and dideoxynucleotide DNA sequencing.
Result: All five methods yielded concordant results of DNA analysis of the hetRM. Differences in real-time PCR cycle threshold values after six-months of storage at -80 °C were not statistically significant from those obtained from freshly prepared hetRM aliquots, which is a good indication of their stability.
Conclusion: By applying the procedures of gene synthesis and cloning technology, we prepared and verified a model genetic reference material for FII G20210A and FV G1691A testing with a compound heterozygous genotype. The hetRM was stable, commutable, and available in large quantities and in a wide concentration range.
Keywords: thrombophilic mutation, gene synthesis, reference material, commutability
Received: April 1, 2014; Accepted: July 8, 2014; Prepublished online: July 18, 2014; Published: December 9, 2014 Show citation
| ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- White HE, Hedges J, Bendit I, Branford S, Colomer D, Hochhaus A, Hughes T, Kamel-Reid S, Kim DW, Modur V, Müller MC, Pagnano KB, Pane F, Radich J, Cross NC, Labourier E. Establishment and validation of analytical reference panels for the standardization of quantitative BCR-ABL1 measurements on the international scale. Clin Chem 2013;59:938-48.
Go to original source...
Go to PubMed... - Hawkins M, Boyle J, Wright KE, Elles R, Ramsden SC, O'Grady A, Sweeney M, Barton DE, Burgess T, Moore M, Burns C, Stacey G, Gray E, Metcalfe P, Hawkins JR. Preparation and validation of the first WHO international genetic reference panel for Fragile X syndrome. Eur J Hum Genet 2011;19:10-7.
Go to original source...
Go to PubMed... - Boyle J, Hawkins M, Barton DE, Meaney K, Guitart M, O'Grady A, Tobi S, Ramsden SC, Elles R, Gray E, Metcalfe P, Hawkins JR. Establishment of the first WHO international genetic reference panel for Prader Willi and Angelman syndromes. Eur J Hum Genet 2011;19:857-64.
Go to original source...
Go to PubMed... - Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 1989;77:51-9.
Go to original source...
Go to PubMed... - Hughes RA, Miklos AE, Ellington AD. Gene synthesis: methods and applications. Methods Enzymol 2011;498:277-309.
Go to original source...
Go to PubMed... - Klein CL, Marki-Zay J, Corbisier P, Gancberg D, Cooper S, Gemmati D, Halbmayer WM, Kitchen S, Melegh B, Neumaier M, Oldenburg J, Leibundgut EO, Reitsma PH, Rieger S, Schimmel HG, Spannagl M, Tordai A, Tosetto A, Visvikis S, Zadro R, Mannhalter C. Reference materials (RMs) for analysis of the human factor II (prothrombin) gene G20210A mutation. Clin Chem Lab Med 2005;43:862-8.
Go to original source...
Go to PubMed... - Gray E, Hawkins JR, Morrison M, Hawkins M, Byrne E, Kitchen S, Jennings I, Makris M, Preston FE, Metcalfe P. Establishment of the 1st International Genetic Reference Panel for Factor V Leiden, human gDNA. Thromb Haemost 2006;96:215-9.
Go to original source...
Go to PubMed... - Crowther MA, Kelton JG. Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system. Ann Intern Med 2003;138:128-34.
Go to original source...
Go to PubMed... - Bauer KA. The thrombophilias: well-defined risk factors with uncertain therapeutic implications. Ann Intern Med 2001;135:367-73.
Go to original source...
Go to PubMed... - Crockett AO, Wittwer CT. Fluorescein-labeled oligonucleotides for real-time PCR: using the inherent quenching of deoxyguanosine nucleotides. Anal Biochem 2001;290:89-97.
Go to original source...
Go to PubMed... - Louis M, Dekairelle AF, Gala JL. Rapid combined genotyping of factor V, prothrombin and methylenetetrahydrofolate reductase single nucleotide polymorphisms using minor groove binding DNA oligonucleotides (MGB probes) and real-time polymerase chain reaction. Clin Chem Lab Med 2004;42:1364-9.
Go to original source...
Go to PubMed... - Stirling D. Multiplex amplification refractory mutation system for the detection of prothrombotic polymorphisms. In: Bartlett JMS, Stirling D, editors. PCR protocols, second edition. New Jersey: Humana Press; 2003. p.323-327.
Go to original source... - Ramsden SC, Deans Z, Robinson DO, Mountford R, Sistermans EA, Grody WW, McQuaid S, Patton SJ, Stenhouse SA. Monitoring standards for molecular genetic testing in the United Kingdom, the Netherlands, and Ireland. Genet Test 2006;10:147-56.
Go to original source...
Go to PubMed... - Endler G, Mannhalter C. Polymorphisms in coagulation factor genes and their impact on arterial an venous thrombosis. Clin Chim Acta 2003;330:31-55.
Go to original source...
Go to PubMed... - Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-703.
Go to original source... - Rosendaal FR, Siscovick DS, Schwartz SM, Beverly RK, Psaty BM, Longstreth WT Jr, Raghunathan TE, Koepsell TD, Reitsma PH. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 1997;89:2817-21.
Go to original source... - De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, Rossi E, Leone G. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med 1999;341:801-6.
Go to original source...
Go to PubMed...




